Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 4, 2015, Pages 1256-1266

  Bellanger, Martine ^a   Demeneix, Barbara ^b   Grandjean, Philippe ^c,d   Zoeller, R Thomas ^e   Trasande, Leonardo ^f,g,h,i  

^a EHESP School of Public Health   (France)

^b MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e UNIVERSITY OF MASSACHUSETTS   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NEW YORK UNIVERSITY   (United States)

^h NEW YORK UNIVERSITY   (United States)

ⁱ NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCRINE DISRUPTOR; ORGANOPHOSPHATE PESTICIDE; POLYBROMINATED DIPHENYL ETHER;

ARTICLE; ATTENTION DEFICIT DISORDER; ATTRIBUTABLE RISK; AUTISM; COST OF ILLNESS; DEVELOPMENTAL DISORDER; DEVELOPMENTAL TOXICITY; EUROPEAN UNION; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; NEUROTOXICITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PRODUCTIVITY; ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHEMICALLY INDUCED; CHILD; ECONOMICS; ENDOCRINE SYSTEM DISEASES; ENVIRONMENTAL EXPOSURE; EUROPE; FEMALE; INTELLECTUAL DISABILITY; MALE; MENTAL DISORDERS; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA;

ANIMALIA;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; ENDOCRINE DISRUPTORS; ENDOCRINE SYSTEM DISEASES; ENVIRONMENTAL EXPOSURE; EUROPE; EUROPEAN UNION; FEMALE; HUMANS; INTELLECTUAL DISABILITY; MALE; MENTAL DISORDERS;

EID: 84927589019     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-4323     Document Type: Article

References (88)

1. Grandjean P, Landrigan PJ. Neurobehavioural effects of developmental toxicity. Lancet Neurol. 2014;13:330-338.
2. Grandjean P. Only One Chance. How Environmental Pollution Impairs Brain Development- and How to Protect the Brains of the Next Generation. New York, NY: Oxford University Press; 2013.
3. Weiss B. The intersection of neurotoxicology and endocrine disruption. Neurotoxicology. 2012;33:1410-1419.
4. Chatonnet F, Flamant F, Morte B. A temporary compendium of thyroid hormone target genes in brain. Biochim Biophys Acta. 2015;1849:122-129.
5. Bernal J. Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab. 2007;3:249-259.
6. Zoeller RT, Rovet J. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol. 2004;16:809-818.
7. Demeneix B. Losing our minds: chemical pollution and the mental health of future generations. Oxford series in behavioral neuroendocrinology, Oxford University Press, 2014.
8. Wise A, Parham F, Axelrad DA, et al. Upstream adverse effects in risk assessment: A model of polychlorinated biphenyls, thyroid hormone disruption and neurological outcomes in humans. Environ Res. 2012;117:90-99.
9. Brown AS, Surcel HM, Hinkka-Yli-Salomäki S, Cheslack-Postava K, Bao Y, Sourander A. Maternal thyroid autoantibody and elevated risk of autism in a national birth cohort. Prog Neuropsychopharmacol Biol Psychiatry. 2015;57:86-92.
10. Yau VM, Lutsky M, Yoshida CK, et al. Prenatal and neonatal thyroid stimulating hormone levels and autism spectrum disorders. J Autism Dev Disord. 2015;45:719-730.
11. Berbel P, Navarro D, Román GC. An evo-devo approach to thyroid hormones in cerebral and cerebellar cortical development: etiological implications for autism. Front Endocrinol (Lausanne). 2014;5:146.
12. Andersen SL, Laurberg P, Wu CS, Olsen J. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study. BJOG. 2014;121:1365-1374.
13. Boas M, Feldt-Rasmussen U, Main KM. Thyroid effects of endocrine disrupting chemicals. Mol Cell Endocrinol. 2012;355:240-248.
14. Bergman A, Heindel JJ, Jobling S, Kidd KA, Zoeller RT. State of the Science of Endocrine Disrupting Chemicals-2012. Geneva, Switzerland: United National Environment Programme and World Health Organization; 2013.
15. Elsabbagh M, Divan G, Koh YJ, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res. 2012;5:160-179.
16. Baxter AJ, Brugha TS, Erskine HE, Scheurer RW, Vos T, Scott JG. The epidemiology and global burden of autism spectrum disorders. Psychol Med. 2015;45:601-613.
17. Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics. 2012;9:490-499.
18. Landrigan PJ. What causes autism? Exploring the environmental contribution. Curr Opin Pediatr. 2010;22:219-225.
19. Bouchard MF, Bellinger DC, Wright RO, Weisskopf MG. Attentiondeficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics. 2010;125:e1270-e1277.
20. Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U. S. children. Environ Health Perspect. 2006;114:1904-1909.
21. Braun JM, Kalkbrenner AE, Just AC, et al. Gestational exposure to endocrine-disrupting chemicals and reciprocal social, repetitive, and stereotypic behaviors in 4- and 5-year-old children: the HOME study. Environ Health Perspect. 2014;122:513-520.
22. Marks AR, Harley K, Bradman A, et al. Organophosphate pesticide exposure and attention in young Mexican-American children: the CHAMACOS study. Environ Health Perspect. 2010;118:1768-1774.
23. Gascon M, Vrijheid M, Martínez D, et al. Effects of pre and postnatal exposure to low levels of polybromodiphenyl ethers on neurodevelopment and thyroid hormone levels at 4 years of age. Environ Int. 2011;37:605-611.
24. Buescher AV, Cidav Z, Knapp M, Mandell DS. Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatrics. 2014;168:721-728.
25. Le HH, Hodgkins P, Postma MJ, et al. Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case. Eur Child Adolesc Psychiatry. 2014;23:587-598.
26. Bartlett ES, Trasande L. Economic impacts of environmentally attributable childhood health outcomes in the European Union. Eur J Public Health. 2014;24:21-26.
27. Bouchard MF, Chevrier J, Harley KG, et al. Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. Environ Health Perspect. 2011;119:1189-1195.
28. Eskenazi B, Chevrier J, Rauch SA, et al. In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study. Environ Health Perspect. 2013;121:257-262.
29. Chen A, Yolton K, Rauch SA, et al. Prenatal polybrominated diphenyl ether exposures and neurodevelopment in U. S. children through 5 years of age: the HOME Study. Environ Health Perspect. 2014;122(8):856-862.
30. Bellanger M, Pichery C, Aerts D, et al. Economic benefits of methylmercury exposure control in Europe: monetary value of neurotoxicity prevention. Environ Health. 2013;12:3.
31. Prüss-Ustün A, Vickers C, Haefliger P, Bertollini R. Knowns and unknowns on burden of disease due to chemicals: a systematic review. Environ Health. 2011;10:9.
32. Intergovernmental Panel on Climate Change. Guidance notes for lead authors of the IPCC Fourth Assessment Report on Addressing Uncertainties. http://www.ipcc.ch/meetings/ar4-workshops-express-meetings/uncertainty-guidance-note.pdf. Published July 2005. Accessed May 12, 2014.
33. Boas M, Frederiksen H, Feldt-Rasmussen U, et al. Childhood exposure to phthalates: associations with thyroid function, insulin-like growth factor I, and growth. Environ Health Perspect. 2010;118:1458-1464.
34. Trasande L, Zoeller RT, Hass U, et al. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015;100:1245-1255.
35. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.
36. Schünemann HJ, Schünemann AH, Oxman AD, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336:1106-1110.
37. Hass U, Christiansen S, Axelstad M, et al. Evaluation of 22 SIN List 2.0 substances according to the Danish proposal on criteria for endocrine disrupters. http://eng.mst.dk/media/mst/67169/SIN%20report%20 and%20Annex.pdf. Published May 2012. Accessed May 12, 2014.
38. Herbstman JB, Sjödin A, Kurzon M, et al. Prenatal exposure to PBDEsand neurodevelopment. Environ Health Perspect. 2010;118:712-719.
39. Eurostat. Births in European Countries, 2010. http://ec.europa.eu/eurostat/tgm/table.do?tab=table&init=1&language=en&pcode=tps00111&plugin=1. Accessed October 3, 2014.
40. Engel SM, Wetmur J, Chen J, et al. Prenatal exposure to organophosphates, paraoxonase 1, and cognitive development in childhood. Environ Health Perspect. 2011;119:1182-1188.
41. Bellinger DC. A strategy for comparing the contributions of environmental chemicals and other risk factors to neurodevelopment of children. Environ Health Perspect. 2012;120:501-507.
42. Miodovnik A, Engel SM, Zhu C, et al. Endocrine disruptors and childhood social impairment. Neurotoxicology. 2011;32:261-267.
43. Wigham S, McConachie H, Tandos J, Le Couteur AS. The reliability and validity of the social responsiveness scale in a UK general child population. Res Dev Disabil. 2012;33:944-950.
44. Eurostat. People by age group, European Union. http://ec.europa.eu/eurostat/tgm/table.do?tab=table&init=1&language=en&pcode=tps00010&plugin=1. Accessed August 25, 2014.
45. Levin M. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum. 1953;9:531-541.
46. Zhang J, Yu KF. What's the relative risk? Amethod of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690-1691.
47. Chen A, Yolton K, Rauch SA, et al. Prenatal polybrominated diphenyl ether exposures and neurodevelopment in U. S. children through 5 years of age: the HOME study. Environ Health Perspect. 2014;122:856-862.
48. Abdelouahab N, Suvorov A, Pasquier JC, Langlois MF, Praud JP, Takser L. Thyroid disruption by low-dose BDE-47 in prenatally exposed lambs. Neonatology. 2009;96:120-124.
49. Brasseur C, Pirard C, Scholl G, et al. Levels of dechloranes and polybrominated diphenyl ethers (PBDEs) in human serum from France. Environ Int. 2014;65:33-40.
50. Lenters V, Thomsen C, Smit LA, et al. Serum concentrations of polybrominated diphenyl ethers (PBDEs) and a polybrominated biphenyl (PBB) in men from Greenland, Poland and Ukraine. Environ Int. 2013;61:8-16.
51. Garí M, Grimalt JO. Inverse age-dependent accumulation of decabromodiphenyl ether and other PBDEs in serum from a general adult population. Environ Int. 2013;54:119-127.
52. Eriksson P, Jakobsson E, Fredriksson A. Brominated flame retardoi dants: a novel class of developmental neurotoxicants in our environment? Environ Health Perspect. 2001;109:903-908.
53. U. S. Environmental Protection Agency. Toxicological review of 2, 2', 4, 4'-tetrabromodiphenyl ether (BDE-47). http://www.epa.gov/iris/toxreviews/1010tr.pdf. Published June 2008. Accessed October 3, 2014.
54. European Food Safety Authority. Scientific opinion on polybrominated diphenyl ethers (PBDEs) in food. http://www.efsa.europa.eu/en/efsajournal/doc/2156.pdf. Published August 4, 2014. Accessed October 3, 2014.
55. Shimizu R, Yamaguchi M, Uramaru N, et al. Structure-activity relationships of 44 halogenated compounds for iodotyrosine deiodinaseinhibitory activity. Toxicology. 2013;314:22-29.
56. de Escobar GM, Ares S, Berbel P, Obregón MJ, del Rey FE. The changing role of maternal thyroid hormone in fetal brain development. Semin Perinatol. 2008;32:380-386.
57. Oerbeck B, Sundet K, Kase BF, Heyerdahl S. Congenital hypothyroidism: no adverse effects of high dose thyroxine treatment on adult memory, attention, and behaviour. Arch Dis Child. 2005;90:132-137.
58. Gee JR, Hedge JM, Moser VC. Lack of alterations in thyroid hormones following exposure to polybrominated diphenyl ether 47 during a period of rapid brain development in mice. Drug Chem Toxicol. 2008;31:245-254.
59. Costa LG, de Laat R, Tagliaferri S, Pellacani C. A mechanistic view of polybrominated diphenyl ether (PBDE) developmental neurotoxicity. Toxicol Lett. 2014;230:282-294.
60. Rauh VA, Garfinkel R, Perera FP, et al. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics. 2006;118:e1845-e1859.
61. De Angelis S, Tassinari R, Maranghi F, et al. Developmental exposure to chlorpyrifos induces alterations in thyroid and thyroid hormone levels without other toxicity signs in CD-1 mice. Toxicol Sci. 2009;108:311-319.
62. Jeong SH, Kim BY, Kang HG, Ku HO, Cho JH. Effect of chlorpyrifosmethyl on steroid and thyroid hormones in rat F0- and F1-generations. Toxicology. 2006;220:189-202.
63. Levin ED, Addy N, Baruah A, et al. Prenatal chlorpyrifos exposure in rats causes persistent behavioral alterations. Neurotoxicol Teratol. 2002;24:733-741.
64. Berbel P, Ausó E, García-Velasco JV, Molina ML, Camacho M. Role of thyroid hormones in the maturation and organisation of rat barrel cortex. Neuroscience. 2001;107:383-394.
65. Engel SM, Wetmur J, Chen J, et al. Prenatal exposure to organophosphates, paraoxonase 1, and cognitive development in childhood. Environ Health Perspect. 2011;119:1182-1188.
66. Rosenberg RE, Law JK, Yenokyan G, McGready J, Kaufmann WE, Law PA. Characteristicsandconcordance of autism spectrum disordersamong 277 twin pairs. Arch Pediatr Adolesc Med. 2009;163:907-914.
67. National Research Council Committee on Developmental Toxicology. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: National Academies Press; 2000.
68. Román GC, Ghassabian A, Bongers-Schokking JJ, et al. Association of gestational maternal hypothyroxinemia and increased autism risk. Ann Neurol. 2013;74:733-742.
69. Kalkbrenner AE, Schmidt RJ, Penlesky AC. Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence. Curr Probl Pediatr Adolesc Health Care. 2014;44:277-318.
70. Toppari J, Virtanen HE, Main KM, Skakkebaek NE. Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection. Birth Defects Res A Clin Mol Teratol. 2010;88:910-919.
71. O'Connor JC, Frame SR, Ladics GS. Evaluation of a 15-day screening assay using intact male rats for identifying steroid biosynthesis inhibitors and thyroid modulators. Toxicol Sci. 2002;69:79-91.
72. Meeker JD, Ferguson KK. Relationship between urinary phthalate and bisphenol A concentrations and serum thyroid measures in U. S. adults and adolescents from the National Health and Nutrition Examination Survey (NHANES) 2007-2008. Environ Health Perspect. 2011;119:1396-1402.
73. Weiss RE, Stein MA, Trommer B, Refetoff S. Attention-deficit hyperactivity disorder and thyroid function. J Pediatr. 1993;123:539-545.
74. Refetoff S, Dumitrescu AM. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab. 2007;21:277-305.
75. McDonald MP, Wong R, Goldstein G, Weintraub B, Cheng SY, Crawley JN. Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone α1 receptor gene. Learn Mem. 1998;5:289-301.
76. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341:549-555.
77. Akaike M, Kato N, Ohno H, Kobayashi T. Hyperactivity and spatial maze learning impairment of adult rats with temporary neonatal hypothyroidism. Neurotoxicol Teratol. 1991;13:317-322.
78. Kiguchi M, Fujita S, Oki H, Shimizu N, Cools AR, Koshikawa N. Behavioural characterisation of rats exposed neonatally to bisphenol-A: responses to a novel environment and to methylphenidate challenge in a putative model of attention-deficit hyperactivity disorder. J Neural Transm. 2008;115:1079-1085.
79. Sazonova NA, DasBanerjee T, Middleton FA, Gowtham S, Schuckers S, Faraone SV. Transcriptome-wide gene expression in a rat model of attention deficit hyperactivity disorder symptoms: rats developmentally exposed to polychlorinated biphenyls. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:898-912.
80. Trasande L, Liu Y. Reducing the staggering costs of environmental disease in children, estimated at $76.6 billion in 2008. Health Aff (Millwood). 2011;30:863-870.
81. Attina TM, Trasande L. Economic costs of childhood lead exposure in low- and middle-income countries. Environ Health Perspect. 2013;121:1097-1102.
82. Spadaro JV, Rabl A. Global health impacts and costs due to mercury emissions. Risk Anal. 2008;28:603-613.
83. United Nations Environment Programme. Global Alliance to Eliminate Lead in Paints. http://www.unep.org/chemicalsandwaste/LeadCadmium/GAELP/tabid/6176/Default.aspx. Accessed December 14, 2010.
84. United Nations Environment Programme. Partnership for Clean Fuels and Vehicles. http://www.unep.org/transport/new/pcfv/. Accessed December 14, 2010.
85. Trasande L, Schechter CB, Haynes KA, Landrigan PJ. Mental retardation and prenatal methylmercury toxicity. Am J Ind Med. 2006;49:153-158.
86. Engel SM, Miodovnik A, Canfield RL, et al. Prenatal phthalate exposure is associated with childhood behavior and executive functioning. Environ Health Perspect. 2010;118:565-571.
87. Taylor PN, Okosieme OE, Murphy R, et al. Maternal perchlorate levels in women with borderline thyroid function during pregnancy and the cognitive development of their offspring: data from the Controlled Antenatal Thyroid Study. J Clin Endocrinol Metab. 2014;99:4291-4298.
88. Damstra T, Barlow S, Bergman A, Kavlock RJ, Van Der Kraak G. Global Assessment of the State-of-the-Science of Endocrine Disruptors. Geneva, Switzerland: World Health Organization; 2002.